A viral ear infection caused by the spread of varicella-zoster virus to the facial nerves. It is characterized by intense otalgia and a cutaneous vesicular eruption.
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 2 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning geniculate herpes zoster
Updated May 19, 2008
CDC recommends that individuals aged 60 and older receive the shingles vaccine to prevent herpes zoster, which can lead to chronic pain. This guidance aims to enhance awareness and vaccination rates among older adults.
The CDC's Advisory Committee on Immunization Practices recommends a new shingles vaccine for individuals aged 60 and older, aiming to reduce the incidence of herpes zoster and its associated chronic pain. This recommendation could influence vaccination policies and access for older adults.